RedHill Biopharma (Nasdaq: RDHL) announced that it has entered into a license agreement with the University of Minnesota to acquire ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE